Robert Andrew Douglas - 18 Aug 2022 Form 4 Insider Report for RESMED INC (RMD)

Role: President and COO
Signature: Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol: RMD
Transactions as of: 18 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Aug 2022, 15:07:41 UTC
Previous filing: 19 Apr 2022
Next filing: 16 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMD	ResMed Common Stock	Award	$0	+4,328	+25%	$0.000000	21,564	18 Aug 2022	Direct	F1, F2
holding	RMD	ResMed Common Stock						234,995	18 Aug 2022	Douglas Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance-based restricted stock units granted on November 18, 2021. The shares were earned on August 18, 2022, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.
F2	Includes 61.1855 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan.